These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
| Delaware | 04-3099750 | |
| (State or other jurisdiction of | (I.R.S. Employer | |
| incorporation or organization) | Identification Number) | |
| P.O. Box 10212 | 06902-7700 | |
| 56 Top Gallant Road | (Zip Code) | |
| Stamford, CT | ||
| (Address of principal executive offices) |
| Large accelerated filer þ | Accelerated filer o | Non-accelerated filer o | Smaller reporting company o | |||
| (Do not check if a smaller reporting company) |
| ITEM 1. | FINANCIAL STATEMENTS |
| March 31, | December 31, | |||||||
| 2010 | 2009 | |||||||
|
Assets
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 105,913 | $ | 116,574 | ||||
|
Fees receivable, net
|
303,165 | 317,598 | ||||||
|
Deferred commissions
|
63,477 | 70,253 | ||||||
|
Prepaid expenses and other current assets
|
61,717 | 53,400 | ||||||
|
|
||||||||
|
Total current assets
|
534,272 | 557,825 | ||||||
|
Property, equipment and leasehold improvements, net
|
48,090 | 52,466 | ||||||
|
Goodwill
|
509,755 | 513,612 | ||||||
|
Intangible assets, net
|
21,182 | 24,113 | ||||||
|
Other assets
|
67,528 | 67,263 | ||||||
|
|
||||||||
|
Total Assets
|
$ | 1,180,827 | $ | 1,215,279 | ||||
|
|
||||||||
|
Liabilities and Stockholders Equity
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable and accrued liabilities
|
$ | 155,218 | $ | 255,966 | ||||
|
Deferred revenues
|
463,236 | 437,207 | ||||||
|
Current portion of long-term debt
|
264,000 | 205,000 | ||||||
|
|
||||||||
|
Total current liabilities
|
882,454 | 898,173 | ||||||
|
Long-term debt
|
103,000 | 124,000 | ||||||
|
Other liabilities
|
79,421 | 80,571 | ||||||
|
|
||||||||
|
Total Liabilities
|
1,064,875 | 1,102,744 | ||||||
|
Stockholders Equity
|
||||||||
|
Preferred stock, $.01 par value, 5,000,000 shares authorized; none issued or outstanding
|
| | ||||||
|
Common stock, $.0005 par value, 250,000,000 shares authorized; 156,234,416 shares issued
for both periods
|
78 | 78 | ||||||
|
Additional paid-in capital
|
588,027 | 590,864 | ||||||
|
Accumulated other comprehensive income, net
|
9,401 | 11,322 | ||||||
|
Accumulated earnings
|
528,795 | 509,392 | ||||||
|
Treasury stock, at cost, 60,052,945 and 60,356,672 common shares, respectively
|
(1,010,349 | ) | (999,121 | ) | ||||
|
|
||||||||
|
Total Stockholders Equity
|
115,952 | 112,535 | ||||||
|
|
||||||||
|
Total Liabilities and Stockholders Equity
|
$ | 1,180,827 | $ | 1,215,279 | ||||
|
|
||||||||
3
| Three Months Ended | ||||||||
| March 31, | ||||||||
| 2010 | 2009 | |||||||
|
Revenues:
|
||||||||
|
Research
|
$ | 210,673 | $ | 187,688 | ||||
|
Consulting
|
71,639 | 70,319 | ||||||
|
Events
|
13,521 | 15,526 | ||||||
|
|
||||||||
|
Total revenues
|
295,833 | 273,533 | ||||||
|
Costs and expenses:
|
||||||||
|
Cost of services and product development
|
123,046 | 116,644 | ||||||
|
Selling, general and administrative
|
130,568 | 115,564 | ||||||
|
Depreciation
|
6,584 | 6,475 | ||||||
|
Amortization of intangibles
|
2,926 | 399 | ||||||
|
Acquisition and integration charges
|
3,511 | | ||||||
|
|
||||||||
|
Total costs and expenses
|
266,635 | 239,082 | ||||||
|
|
||||||||
|
Operating income
|
29,198 | 34,451 | ||||||
|
Interest expense, net
|
(3,384 | ) | (4,180 | ) | ||||
|
Other income (expense), net
|
1,752 | (1,246 | ) | |||||
|
|
||||||||
|
Income before income taxes
|
27,566 | 29,025 | ||||||
|
Provision for income taxes
|
8,163 | 9,029 | ||||||
|
|
||||||||
|
Net income
|
$ | 19,403 | $ | 19,996 | ||||
|
|
||||||||
|
Income per common share:
|
||||||||
|
Basic
|
$ | 0.20 | $ | 0.21 | ||||
|
|
||||||||
|
Diluted
|
$ | 0.19 | $ | 0.21 | ||||
|
|
||||||||
|
Weighted average shares outstanding:
|
||||||||
|
Basic
|
95,963 | 93,898 | ||||||
|
Diluted
|
99,649 | 95,763 | ||||||
4
| Three Months Ended | ||||||||
| March 31, | ||||||||
| 2010 | 2009 | |||||||
|
Operating activities:
|
||||||||
|
Net income
|
$ | 19,403 | $ | 19,996 | ||||
|
Adjustments to reconcile net income to net cash (used) provided by operating activities:
|
||||||||
|
Depreciation and amortization of intangibles
|
9,510 | 6,874 | ||||||
|
Stock-based compensation expense
|
9,159 | 6,792 | ||||||
|
Excess tax benefits from stock-based compensation
|
(5,188 | ) | (7 | ) | ||||
|
Deferred taxes
|
(873 | ) | 1,130 | |||||
|
Amortization of debt issue costs
|
272 | 361 | ||||||
|
Changes in assets and liabilities:
|
||||||||
|
Fees receivable, net
|
8,799 | 57,688 | ||||||
|
Deferred commissions
|
5,866 | 5,196 | ||||||
|
Prepaid expenses and other current assets
|
(2,520 | ) | 592 | |||||
|
Other assets
|
(6,442 | ) | 2,528 | |||||
|
Deferred revenues
|
30,651 | (19,760 | ) | |||||
|
Accounts payable, accrued, and other liabilities
|
(76,603 | ) | (66,563 | ) | ||||
|
|
||||||||
|
Cash (used) provided by operating activities
|
(7,966 | ) | 14,827 | |||||
|
|
||||||||
|
Investing activities:
|
||||||||
|
Additions to property, equipment and leasehold improvements
|
(3,412 | ) | (4,536 | ) | ||||
|
Acquisitions (net of cash received)
|
(11,696 | ) | | |||||
|
|
||||||||
|
Cash used in investing activities
|
(15,108 | ) | (4,536 | ) | ||||
|
|
||||||||
|
Financing activities:
|
||||||||
|
Proceeds from stock issued for stock plans
|
6,714 | 887 | ||||||
|
Proceeds from debt issuance
|
52,000 | | ||||||
|
Payments on debt
|
(14,000 | ) | (78,250 | ) | ||||
|
Purchases of treasury stock
|
(35,172 | ) | (2,150 | ) | ||||
|
Excess tax benefits from stock-based compensation
|
5,188 | 7 | ||||||
|
|
||||||||
|
Cash provided
(
used
)
by financing activities
|
14,730 | (79,506 | ) | |||||
|
|
||||||||
|
Net decrease in cash and cash equivalents
|
(8,344 | ) | (69,215 | ) | ||||
|
Effects of exchange rates on cash and cash equivalents
|
(2,317 | ) | (1,451 | ) | ||||
|
Cash and cash equivalents, beginning of period
|
116,574 | 140,929 | ||||||
|
|
||||||||
|
Cash and cash equivalents, end of period
|
$ | 105,913 | $ | 70,263 | ||||
|
|
||||||||
5
6
| Three Months Ended | ||||||||
| March 31, | ||||||||
| 2010 | 2009 | |||||||
|
Net income:
|
$ | 19,403 | $ | 19,996 | ||||
|
Other comprehensive (loss) income, net of tax:
|
||||||||
|
Foreign currency translation adjustments
|
(2,540 | ) | 1,188 | |||||
|
Unrealized gain on interest rate swaps
|
704 | 646 | ||||||
|
Amortization of realized gain on terminated interest rate swap
|
(26 | ) | (74 | ) | ||||
|
Amortization of pension unrealized gain
|
(59 | ) | (44 | ) | ||||
|
|
||||||||
|
Other comprehensive (loss) income
|
(1,921 | ) | 1,716 | |||||
|
|
||||||||
|
Comprehensive income
|
$ | 17,482 | $ | 21,712 | ||||
|
|
||||||||
| Three Months Ended | ||||||||
| March 31, | ||||||||
| 2010 | 2009 | |||||||
|
Numerator:
|
||||||||
|
Net income used for calculating basic and diluted earnings per share
|
$ | 19,403 | $ | 19,996 | ||||
|
|
||||||||
|
Denominator:
|
||||||||
|
Weighted average number of common shares used in the calculation of
basic earnings per share
|
95,963 | 93,898 | ||||||
|
Common stock equivalents associated with stock-based compensation
plans (1)
|
3,686 | 1,865 | ||||||
|
|
||||||||
|
Shares used in the calculation of diluted earnings per share
|
99,649 | 95,763 | ||||||
|
|
||||||||
|
Basic earnings per share
|
$ | 0.20 | $ | 0.21 | ||||
|
|
||||||||
|
Diluted earnings per share
|
$ | 0.19 | $ | 0.21 | ||||
|
|
||||||||
| (1) | For the three months ended March 31, 2010 and 2009, 0.5 million and 3.8 million, respectively, of common stock equivalents were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive. |
7
| Three Months Ended | ||||||||
| March 31, | ||||||||
| Award type: | 2010 | 2009 | ||||||
|
Stock appreciation rights (SARs)
|
$ | 1.7 | $ | 1.1 | ||||
|
Common stock equivalents (CSEs)
|
0.1 | 0.1 | ||||||
|
Restricted stock units (RSUs)
|
7.4 | 5.6 | ||||||
|
|
||||||||
|
Total (1)
|
$ | 9.2 | $ | 6.8 | ||||
|
|
||||||||
| (1) | Includes $2.3 million and $1.1 million, respectively, for charges determined in accordance with the Companys retirement-eligible policy. |
| Three Months Ended | ||||||||
| March 31, | ||||||||
| Amount recorded in: | 2010 | 2009 | ||||||
|
Cost of services and product development
|
$ | 4.7 | $ | 3.1 | ||||
|
Selling, general and administrative
|
4.5 | 3.7 | ||||||
|
|
||||||||
|
Total stock-based compensation expense
|
$ | 9.2 | $ | 6.8 | ||||
|
|
||||||||
8
| Per Share | Weighted | |||||||||||||||
| Per Share | Weighted- | Average | ||||||||||||||
| Weighted- | Average | Remaining | ||||||||||||||
| SARs in | Average | Grant Date | Contractual | |||||||||||||
| millions | Exercise Price | Fair Value | Term | |||||||||||||
|
Outstanding at December 31, 2009
|
2.9 | $ | 15.43 | $ | 6.09 | 4.67 years | ||||||||||
|
Granted
|
0.5 | 22.06 | 8.27 | 6.87 years | ||||||||||||
|
Forfeited
|
| | | na | ||||||||||||
|
Exercised
|
(0.3 | ) | 14.48 | 5.99 | na | |||||||||||
|
|
||||||||||||||||
|
Outstanding at March 31, 2010 (1)
|
3.1 | $ | 16.74 | $ | 5.00 | 5.01 years | ||||||||||
|
|
||||||||||||||||
|
Vested and exercisable at March 31, 2010 (1)
|
1.2 | $ | 16.90 | $ | 6.49 | 4.17 years | ||||||||||
|
|
||||||||||||||||
| (1) | At March 31, 2010, SARs outstanding had an intrinsic value of $17.2 million. SARs vested and exercisable had an intrinsic value of $6.7 million. |
| Three Months Ended | ||||||||
| March 31, | ||||||||
| 2010 | 2009 | |||||||
|
Expected dividend yield (1)
|
0 | % | 0 | % | ||||
|
Expected stock price volatility (2)
|
40 | % | 50 | % | ||||
|
Risk-free interest rate (3)
|
2.4 | % | 2.3 | % | ||||
|
Expected life in years (4)
|
4.8 | 4.8 | ||||||
|
|
||||||||
| (1) | The dividend yield assumption is based on the history and expectation of the Companys dividend payouts. Historically, Gartner has not paid cash dividends on its common stock. | |
| (2) | The determination of expected stock price volatility was based on both historical Common Stock prices and implied volatility from publicly traded options in Common Stock. | |
| (3) | The risk-free interest rate is based on the yield of a U.S. Treasury security with a maturity similar to the expected life of the award. | |
| (4) | The expected life in years is based on the simplified calculation provided for in SEC SAB No. 107. The simplified method determines the expected life in years based on the vesting period and contractual terms as set forth when the award is made. The Company continues to use the simplified method for SARs awards, as permitted by SEC SAB No. 110, since it does not have the necessary historical exercise and forfeiture data to determine an expected life. |
9
| Weighted- | Weighted- | Common | Weighted- | |||||||||||||||||||||
| Average | Restricted | Average | Stock | Average | ||||||||||||||||||||
| Restricted | Grant Date | Stock Units | Grant Date | Equivalents | Grant Date | |||||||||||||||||||
| Stock | Fair Value (1) | (RSUs) | Fair Value (1) | (CSEs) | Fair Value (1) | |||||||||||||||||||
|
Outstanding at December 31, 2009
|
200,000 | $ | 7.30 | 3,763,805 | $ | 14.57 | 135,224 | na | ||||||||||||||||
|
Granted (2), (3)
|
| | 1,084,115 | 22.06 | 4,670 | $ | 22.41 | |||||||||||||||||
|
Vested or released
|
| | (952,373 | ) | 15.34 | (31,042 | ) | na | ||||||||||||||||
|
Forfeited
|
| | (39,578 | ) | 16.28 | | na | |||||||||||||||||
|
|
||||||||||||||||||||||||
|
Outstanding at March 31, 2010 (4), (5)
|
200,000 | $ | 7.30 | 3,855,969 | $ | 16.29 | 108,852 | na | ||||||||||||||||
|
|
||||||||||||||||||||||||
| (1) | Per share. | |
| (2) | The 1.1 million RSUs consisted of 0.5 million performance-based RSUs awarded to executives and 0.6 million service-based RSUs awarded to non-executive employees. | |
| The 0.5 million performance-based RSUs represent the target amount of the award. The actual number of RSUs that will ultimately be granted will be between 0% and 200% of the target amount, depending on the level of achievement of the performance metric. The performance metric is the dollar level of the Companys ending subscription-based contract value for 2010. If the specified minimum level of achievement is not met, the performance-based RSUs will be forfeited in their entirety, and any compensation expense already recorded will be reversed. | ||
| (3) | CSEs represent fees paid to directors. The CSEs vest when granted and are convertible into common shares when the director leaves the Board of Directors or earlier if the director elects to accelerate the release. | |
| (4) | Vesting on the 200,000 shares of restricted stock held by our CEO is subject to a market condition as follows: (i) 100,000 shares will vest when the Common Stock trades at an average price of $25 or more each trading day for sixty consecutive trading days; and (ii) 100,000 shares will vest when the Common Stock trades at an average price of $30 or more each trading day for sixty consecutive trading days. There is no remaining unamortized cost on these shares. | |
| (5) | The weighted-average remaining contractual term of the RSUs is 1.7 years. The restricted stock awards and the CSEs have no defined contractual term. |
| Weighted | ||||||||||||||||
| Per Share | Average | |||||||||||||||
| Weighted- | Remaining | Aggregate | ||||||||||||||
| Options in | Average | Contractual | Intrinsic Value | |||||||||||||
| millions | Exercise Price | Term | (in millions) | |||||||||||||
|
Outstanding at December 31, 2009
|
4.7 | $ | 10.65 | 3.07 years | $ | 34.8 | ||||||||||
|
Expired
|
| | na | na | ||||||||||||
|
Exercised (1)
|
(0.6 | ) | 10.19 | na | na | |||||||||||
|
|
||||||||||||||||
|
Outstanding at March 31, 2010
|
4.1 | $ | 10.71 | 2.89 years | $ | 47.6 | ||||||||||
|
|
||||||||||||||||
| (1) | Options exercised during the three months ended March 31, 2010 had an intrinsic value of $7.6 million. |
10
| Research | Consulting | Events | Consolidated | |||||||||||||
|
Three Months Ended March 31, 2010:
|
||||||||||||||||
|
Revenues
|
$ | 210,673 | $ | 71,639 | $ | 13,521 | $ | 295,833 | ||||||||
|
Gross contribution
|
138,735 | 28,422 | 5,215 | 172,372 | ||||||||||||
|
Corporate and other expenses
|
(143,174 | ) | ||||||||||||||
|
|
||||||||||||||||
|
Operating income
|
$ | 29,198 | ||||||||||||||
|
|
||||||||||||||||
| Research | Consulting | Events | Consolidated | |||||||||||||
|
Three Months Ended March 31, 2009:
|
||||||||||||||||
|
Revenues
|
$ | 187,688 | $ | 70,319 | $ | 15,526 | $ | 273,533 | ||||||||
|
Gross contribution
|
124,731 | 27,020 | 4,783 | 156,534 | ||||||||||||
|
Corporate and other expenses
|
(122,083 | ) | ||||||||||||||
|
|
||||||||||||||||
|
Operating income
|
$ | 34,451 | ||||||||||||||
|
|
||||||||||||||||
11
| Research | Consulting | Events | Total | |||||||||||||
|
Balance, December 31, 2009
|
$ | 370,630 | $ | 100,744 | $ | 42,238 | $ | 513,612 | ||||||||
|
Foreign currency translation adjustments
|
(2,833 | ) | (962 | ) | (62 | ) | (3,857 | ) | ||||||||
|
|
||||||||||||||||
|
Balance, March 31, 2010
|
$ | 367,797 | $ | 99,782 | $ | 42,176 | $ | 509,755 | ||||||||
|
|
||||||||||||||||
| Customer | Noncompete | |||||||||||||||||||
| March 31, 2010 | Content | Trade Name | Relationships | Agreements | Total | |||||||||||||||
|
Gross cost
|
$ | 10,634 | $ | 5,758 | $ | 14,910 | $ | 401 | $ | 31,703 | ||||||||||
|
Accumulated amortization
|
(1,772 | ) | (288 | ) | (8,150 | ) | (311 | ) | (10,521 | ) | ||||||||||
|
|
||||||||||||||||||||
|
Net
|
$ | 8,862 | $ | 5,470 | $ | 6,760 | $ | 90 | $ | 21,182 | ||||||||||
|
|
||||||||||||||||||||
| Customer | Noncompete | |||||||||||||||||||
| December 31, 2009 | Content | Trade Name | Relationships | Agreements | Total | |||||||||||||||
|
Gross cost
|
$ | 10,634 | $ | 5,758 | $ | 14,910 | $ | 416 | $ | 31,718 | ||||||||||
|
Accumulated amortization
|
| | (7,315 | ) | (290 | ) | (7,605 | ) | ||||||||||||
|
|
||||||||||||||||||||
|
Net
|
$ | 10,634 | $ | 5,758 | $ | 7,595 | $ | 126 | $ | 24,113 | ||||||||||
|
|
||||||||||||||||||||
| Customer | Noncompete | |||||||||||||||
| Content | Trade Name | Relationships | Agreements | |||||||||||||
|
Useful Life (Years)
|
1.5 | 5 | 4 | 2-5 | ||||||||||||
|
2010 (remaining nine months)
|
$ | 7,605 | ||
|
2011
|
6,525 | |||
|
2012
|
2,955 | |||
|
2014
|
2,955 | |||
|
2015 and thereafter
|
1,142 | |||
|
|
||||
|
|
$ | 21,182 | ||
|
|
||||
12
| Amount | Amount | Annualized | ||||||||||
| Outstanding | Outstanding | Effective | ||||||||||
| December 31, 2009 | March 31, 2010 | Interest Rates | ||||||||||
| (In thousands) | (In thousands) | March 31, 2010 (3) | ||||||||||
|
Description:
|
||||||||||||
|
Original Term Loan (1)
|
$ | 126,000 | $ | 117,000 | 5.94 | % | ||||||
|
2008 Term Loan (1)
|
75,000 | 70,000 | 1.55 | % | ||||||||
|
Revolver (2)
|
128,000 | 180,000 | 1.15 | % | ||||||||
|
|
||||||||||||
|
Total
|
$ | 329,000 | $ | 367,000 | ||||||||
|
|
||||||||||||
| (1) | During the three months ended March 31, 2010, the Company repaid $9.0 million of the original term loan and $5.0 million of the 2008 term loan pursuant to the loan amortization schedules. | |
| (2) | The Company had approximately $118.6 million of available borrowing capacity on the revolver (not including the expansion feature) as of March 31, 2010. | |
| (3) | The annualized effective rate on the original term loan consisted of the interest rate swap rate (see below) of 5.06% plus a margin of 0.88%. The effective rate on the 2008 term loan consisted of a three-month LIBOR base rate plus a margin of 1.25%, while the revolver rate consisted of a LIBOR base rate plus a margin of 0.88%. |
13
| Three Months Ended | ||||||||
| March 31, | ||||||||
| 2010 | 2009 | |||||||
|
Number of shares repurchased
|
1,503,700 | 186,694 | ||||||
|
Cost of repurchased shares (in thousands):
|
$ | 35,172 | $ | 2,150 | ||||
|
|
||||||||
14
| Number of | Contract | Fair Value | Balance | Gain (Loss) | ||||||||||||||||
| Outstanding | Notional | Asset | Sheet | Recorded in | ||||||||||||||||
| Derivative Contract Type | Contracts | Amount | (Liability) (4) | Line Item | OCI (5) | |||||||||||||||
|
Interest Rate Swap (1)
|
1 | $ | 117,000 | $ | (5,764 | ) | Other liabilities | $ | (3,458 | ) | ||||||||||
|
Interest Rate Swap (2)
|
1 | 105,000 | (2,643 | ) | Other liabilities | (884 | ) | |||||||||||||
|
Foreign Currency Forwards (3)
|
14 | 58,500 | (214 | ) | Accrued liabilities | | ||||||||||||||
|
Total
|
16 | $ | 280,500 | $ | (8,621 | ) | $ | (4,342 | ) | |||||||||||
| Number of | Contract | Fair Value | Balance | Gain (Loss) | ||||||||||||||||
| Outstanding | Notional | Asset | Sheet | Recorded in | ||||||||||||||||
| Derivative Contract Type | Contracts | Amount | (Liability) (4) | Line Item | OCI (5) | |||||||||||||||
|
Interest Rate Swap (1)
|
1 | $ | 126,000 | $ | (6,594 | ) | Other liabilities | $ | (3,956 | ) | ||||||||||
|
Interest Rate Swap (2)
|
1 | 112,500 | (2,769 | ) | Other liabilities | (1,090 | ) | |||||||||||||
|
Foreign Currency Forwards (3)
|
19 | 117,296 | 740 | Other current assets | | |||||||||||||||
|
Total
|
21 | $ | 355,796 | $ | (8,623 | ) | $ | (5,046 | ) | |||||||||||
| (1) | The Company designates and accounts for this interest rate swap as a cash flow hedge of debt (see Note 8 Debt). | |
| (2) | Prior to September 30, 2009, the Company accounted for this interest rate swap as a cash flow hedge of debt. On September 30, 2009, the Company discontinued hedge accounting on this interest rate swap and as a result, the remaining unrecognized loss in OCI is being amortized against earnings through the maturity of the previously hedged debt. | |
| (3) | The Company has foreign exchange transaction risk since it typically enters into transactions in the normal course of business that are denominated in foreign currencies that differ from the local functional currencies in which the Company and its subsidiaries operate. The Company may enter into foreign currency forward exchange contracts to offset the effects of this foreign currency transaction risk. These contracts are normally short term in duration. Both realized and unrealized gains and losses are recognized in earnings since the Company does not designate these contracts as hedges for accounting purposes. | |
| (4) | See Note 12 Fair Value Disclosures for the determination of the fair value of these instruments. | |
| (5) | Represents the amount recorded in Other comprehensive income (OCI), net of tax effect. |
| Three Months Ended | ||||||||
| March 31, | ||||||||
| Amount recorded in: | 2010 | 2009 | ||||||
|
Interest expense, net (1)
|
$ | 2,443 | $ | 1,852 | ||||
|
Other expense (income), net (2)
|
726 | (2,281 | ) | |||||
|
|
||||||||
|
Total expense (income), net
|
$ | 3,169 | $ | (429 | ) | |||
|
|
||||||||
| (1) | Includes amounts reclassified from OCI to earnings during the period for interest rate swap contracts. | |
| (2) | Includes the net amount of realized and unrealized gains and losses on foreign currency forward contracts. |
15
| | Level 1 Valuation inputs are unadjusted quoted market prices for identical assets or liabilities in active markets. |
| | Level 2 Valuation inputs are quoted prices for identical assets or liabilities in markets that are not active, quoted market prices for similar assets and liabilities in active markets and other observable inputs directly or indirectly related to the asset or liability being measured. |
| | Level 3 Valuation inputs are unobservable and significant to the fair value measurement. |
| Fair Value | ||||
| March 31, 2010 | ||||
|
Description:
|
||||
|
Assets:
|
||||
|
Deferred compensation assets (1)
|
$ | 21,119 | ||
|
|
||||
|
Liabilities:
|
||||
|
Interest rate swap contracts (2)
|
$ | 8,406 | ||
|
Foreign currency forward contracts (3)
|
214 | |||
|
|
||||
|
|
$ | 8,620 | ||
|
|
||||
| (1) | The Company has a supplemental deferred compensation arrangement for the benefit of certain highly compensated officers, managers and other key employees. The assets consist of investments in money market and mutual funds, and company-owned life insurance. The money market and mutual funds consist of cash equivalents or securities traded in active markets, which the Company considers the fair value of these assets to be based on a Level 1 input. The value of the Company-owned life insurance is based on indirectly observable prices which the Company considers to be Level 2 inputs. | |
| (2) | The Company has two interest rate swap contracts (see Note 11Derivatives and Hedging). To determine the fair value of the swaps, the Company relies on mark-to-market valuations prepared by third-party brokers based on observable interest rate yield curves. Accordingly, the fair value of the swaps is determined under a Level 2 input. | |
| (3) | The Company periodically enters into foreign currency forward exchange contracts to hedge the effects of adverse fluctuations in foreign currency exchange rates (see Note 11Derivatives and Hedging). Valuation of the foreign currency forward contracts is based on foreign currency exchange rates in active markets; thus the Company measures the fair value of these contracts under a Level 2 input. |
16
17
| | Research provides insight for CIOs, other IT executives and professionals, business leaders, technology companies and the investment community through research reports and briefings, access to our analysts, as well as peer networking services and membership programs. |
| | Consulting consists primarily of client engagements that utilize our research insight, benchmarking data, problem-solving methodologies and hands on experience to improve the return on an organizations IT investment through assessments of cost, performance, efficiency and quality. |
| | Events consists of various symposia, summits, and conferences focused on the IT industry as a whole, as well as IT applicable to particular industries and particular roles within an organization. |
18
| BUSINESS SEGMENT | BUSINESS MEASUREMENTS | |
| Research |
Contract value
represents the value attributable to all of our subscription-related
research products that recognize revenue on a ratable basis. Contract value is calculated
as the annualized value of all subscription research contracts in effect at a specific
point in time, without regard to the duration of the contract.
|
|
|
|
||
|
Client retention rate
represents a measure of client satisfaction and renewed business
relationships at a specific point in time. Client retention is calculated on a percentage
basis by dividing our current clients, who were also clients a year ago, by all clients
from a year ago.
|
||
|
|
||
|
Wallet retention rate
represents a measure of the amount of contract value we have
retained with clients over a twelve-month period. Wallet retention is calculated on a
percentage basis by dividing the contract value of clients, who were clients one year
earlier, by the total contract value from a year earlier, excluding the impact of foreign
currency exchange. When wallet retention exceeds client retention, it is an indication of
retention of higher-spending clients, or increased spending by retained clients, or both.
|
||
|
|
||
|
Number of executive program members
represents the number of paid participants in
executive programs.
|
||
|
|
||
| Consulting |
Consulting backlog
represents future revenue to be derived from in-process consulting,
measurement and strategic advisory services engagements.
|
|
|
|
||
|
Utilization rates
represent a measure of productivity of our consultants. Utilization
rates are calculated for billable headcount on a percentage basis by dividing total hours
billed by total hours available to bill.
|
||
|
|
||
|
Billing Rate
represents earned billable revenue divided by total billable hours.
|
||
|
|
||
|
Average annualized revenue per billable headcount
represents a measure of the revenue
generating ability of an average billable consultant and is calculated periodically by
multiplying the average billing rate per hour times the utilization percentage times the
billable hours available for one year.
|
||
|
|
||
| Events |
Number of events
represents the total number of hosted events completed during the period.
|
|
|
|
||
|
Number of attendees
represents the number of people who attend events.
|
19
| | Research revenues are derived from subscription contracts for research products and are deferred and recognized ratably over the applicable contract term. Fees from research reprints are recognized when the reprint is shipped. | ||
| | Consulting revenues are principally generated from fixed fee and time and material engagements. Revenues from fixed fee contracts are recognized on a percentage of completion basis. Revenues from time and materials engagements are recognized as work is delivered and/or services are provided. Revenues related to contract optimization contracts are contingent in nature and are only recognized upon satisfaction of all conditions related to their payment. | ||
| | Events revenues are deferred and recognized upon the completion of the related symposium, conference or exhibition. |
| March 31, | December 31, | |||||||
| 2010 | 2009 | |||||||
|
Total fees receivable
|
$ | 311,365 | $ | 325,698 | ||||
|
Allowance for losses
|
(8,200 | ) | (8,100 | ) | ||||
|
|
||||||||
|
Fees receivable, net
|
$ | 303,165 | $ | 317,598 | ||||
|
|
||||||||
20
| | Significant under-performance relative to historical or projected future operating results; | |
| | Significant changes in the manner of our use of acquired assets or the strategy for our overall business; | |
| | Significant negative industry or economic trends; | |
| | Significant decline in our stock price for a sustained period; and | |
| | Our market capitalization relative to net book value. |
21
| Three Months | Three Months | Income | Income | |||||||||||||
| Ended | Ended | Increase | Increase | |||||||||||||
| March 31, | March 31, | (Decrease) | (Decrease) | |||||||||||||
| 2010 (1) | 2009 | In $ | In % | |||||||||||||
|
Total revenues
|
$ | 295,833 | $ | 273,533 | $ | 22,300 | 8 | % | ||||||||
|
Costs and expenses:
|
||||||||||||||||
|
Cost of services & product development
|
123,046 | 116,644 | (6,402 | ) | (5 | )% | ||||||||||
|
Selling, general and administrative
|
130,568 | 115,564 | (15,004 | ) | (13 | )% | ||||||||||
|
Depreciation
|
6,584 | 6,475 | (109 | ) | (2 | )% | ||||||||||
|
Amortization of intangibles
|
2,926 | 399 | (2,527 | ) | >(100 | )% | ||||||||||
|
Acquisition & integration charges
|
3,511 | | (3,511 | ) | (100 | )% | ||||||||||
|
|
||||||||||||||||
|
Operating income
|
29,198 | 34,451 | (5,253 | ) | (15 | )% | ||||||||||
|
Interest expense, net
|
(3,384 | ) | (4,180 | ) | 796 | 19 | % | |||||||||
|
Other income (expense), net
|
1,752 | (1,246 | ) | 2,998 | >100 | % | ||||||||||
|
Provision for income taxes
|
8,163 | 9,029 | 866 | 10 | % | |||||||||||
|
|
||||||||||||||||
|
Net income
|
$ | 19,403 | $ | 19,996 | $ | (593 | ) | (3 | )% | |||||||
|
|
||||||||||||||||
| (1) | Includes the operating results of AMR Research and Burton Group, which we acquired in December 2009. |
22
23
| As Of And | As Of And | |||||||||||||||
| For The | For The | |||||||||||||||
| Three Months | Three Months | |||||||||||||||
| Ended | Ended | Percentage | ||||||||||||||
| March 31, | March 31, | Increase | Increase | |||||||||||||
| 2010 (1) | 2009 | (Decrease) | (Decrease) | |||||||||||||
|
Financial Measurements:
|
||||||||||||||||
|
Revenues (2)
|
$ | 210,673 | $ | 187,688 | $ | 22,985 | 12 | % | ||||||||
|
Gross contribution (2)
|
$ | 138,735 | $ | 124,731 | $ | 14,004 | 11 | % | ||||||||
|
Gross contribution margin
|
66 | % | 66 | % | | | ||||||||||
|
|
||||||||||||||||
|
Business Measurements:
|
||||||||||||||||
|
Contract value (2)
|
$ | 864,428 | $ | 760,704 | $ | 103,724 | 14 | % | ||||||||
|
Client retention
|
80 | % | 80 | % | | | ||||||||||
|
Wallet retention
|
89 | % | 90 | % | (1) point | | ||||||||||
|
Exec. program members
|
3,825 | 3,573 | 252 | 7 | % | |||||||||||
|
|
||||||||||||||||
| (1) | Includes AMR Research and Burton Group, which we acquired in December 2009. | |
| (2) | Dollars in thousands. |
| As Of And | As Of And | |||||||||||||||
| For The | For The | |||||||||||||||
| Three Months | Three Months | |||||||||||||||
| Ended | Ended | Percentage | ||||||||||||||
| March 31, | March 31, | Increase | Increase | |||||||||||||
| 2010 (1) | 2009 | (Decrease) | (Decrease) | |||||||||||||
|
Financial Measurements:
|
||||||||||||||||
|
Revenues (2)
|
$ | 71,639 | $ | 70,319 | $ | 1,320 | 2 | % | ||||||||
|
Gross contribution (2)
|
$ | 28,422 | $ | 27,020 | $ | 1,402 | 5 | % | ||||||||
|
Gross contribution margin
|
40 | % | 38 | % | 2 points | | ||||||||||
|
|
||||||||||||||||
|
Business Measurements:
|
||||||||||||||||
|
Backlog (2)
|
$ | 89,091 | $ | 86,657 | $ | 2,434 | 3 | % | ||||||||
|
Billable headcount
|
444 | 470 | (26 | ) | (6 | )% | ||||||||||
|
Consultant utilization
|
72 | % | 72 | % | | | ||||||||||
|
Average annualized revenue per billable headcount (2)
|
$ | 441 | $ | 413 | $ | 28 | 7 | % | ||||||||
|
|
||||||||||||||||
| (1) | Includes AMR Research and Burton Group, which we acquired in December 2009. | |
| (2) | Dollars in thousands. |
24
| As Of And | As Of And | |||||||||||||||
| For The | For The | |||||||||||||||
| Three Months | Three Months | |||||||||||||||
| Ended | Ended | Percentage | ||||||||||||||
| March 31, | March 31, | Increase | Increase | |||||||||||||
| 2010 (1) | 2009 | (Decrease) | (Decrease) | |||||||||||||
|
Financial Measurements:
|
||||||||||||||||
|
Revenues (2)
|
$ | 13,521 | $ | 15,526 | $ | (2,005 | ) | (13 | )% | |||||||
|
Gross contribution (2)
|
$ | 5,215 | $ | 4,783 | $ | 432 | 9 | % | ||||||||
|
Gross contribution margin
|
39 | % | 31 | % | 8 points | | ||||||||||
|
|
||||||||||||||||
|
Business Measurements:
|
||||||||||||||||
|
Number of events
|
9 | 12 | (3 | ) | (25 | )% | ||||||||||
|
Number of attendees
|
3,374 | 3,883 | (509 | ) | (13 | )% | ||||||||||
|
|
||||||||||||||||
| (1) | Includes AMR Research and Burton Group, which we acquired in December 2009. | |
| (2) | Dollars in thousands. |
| Three Months | Three Months | |||||||||||||||
| Ended | Ended | Dollar | ||||||||||||||
| March 31, | March 31, | Increase | ||||||||||||||
| 2010 | 2009 | (Decrease) | ||||||||||||||
|
Cash provided by operating activities
|
$ | (7,966 | ) | $ | 14,827 | $ | (22,793 | ) | ||||||||
|
Cash used by investing activities
|
(15,108 | ) | (4,536 | ) | (10,572 | ) | ||||||||||
|
Cash provided (used) in financing activities
|
14,730 | (79,506 | ) | 94,236 | ||||||||||||
|
|
||||||||||||||||
|
Net
(decrease) increase
|
(8,344 | ) | (69,215 | ) | 60,871 | |||||||||||
|
Effects of exchange rates
|
(2,317 | ) | (1,451 | ) | (866 | ) | ||||||||||
|
Beginning cash and cash equivalents
|
116,574 | 140,929 | (24,355 | ) | ||||||||||||
|
|
||||||||||||||||
|
Ending cash and cash equivalents
|
$ | 105,913 | $ | 70,263 | $ | 35,650 | ||||||||||
|
|
||||||||||||||||
25
26
27
28
| Approximate | ||||||||||||
| Dollar Value of | ||||||||||||
| Shares that may | ||||||||||||
| yet be Purchased | ||||||||||||
| Total | Under our Share | |||||||||||
| Number of | Average | Repurchase | ||||||||||
| Shares | Price Paid | Program | ||||||||||
| Period | Purchased | Per Share | (in thousands) | |||||||||
|
2010
|
||||||||||||
|
January
|
2,291 | $ | 21.39 | |||||||||
|
February
|
949,467 | 22.93 | ||||||||||
|
March
|
551,942 | 24.18 | ||||||||||
|
|
||||||||||||
|
Total
|
1,503,700 | $ | 23.39 | $ | 43.5 | |||||||
|
|
||||||||||||
| EXHIBIT | ||
| NUMBER | DESCRIPTION OF DOCUMENT | |
|
31.1
|
Certification of chief executive officer under Rule 13a 14(a)/15d 14(a). | |
|
|
||
|
31.2
|
Certification of chief financial officer under Rule 13a 14(a)/15d 14(a). | |
|
|
||
|
32
|
Certification under 18 U.S.C. 1350. |
29
|
Gartner, Inc.
|
||||
| Date May 5, 2010 | /s/ Christopher J. Lafond | |||
| Christopher J. Lafond | ||||
|
Executive Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer) |
||||
30
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|